Dupont Capital Management Corp Allakos Inc. Transaction History

Dupont Capital Management Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 31, 2022	SELL	$8.55 - $111.89 $12,525 - $163,918	-1,465 Closed	0 $0
Q3 2021 Nov 03, 2021	BUY	$76.53 - $110.43 $112,116 - $161,779	1,465 New	1,465 $155,000
Q4 2020 Jan 28, 2021	SELL	$79.58 - $152.45 $390,976 - $748,986	-4,913 Closed	0 $0
Q3 2020 Oct 29, 2020	BUY	$66.43 - $90.99 $81,775 - $112,008	1,231 Added 33.43%	4,913 $400,000
Q2 2020 Jul 24, 2020	BUY	$44.04 - $80.69 $162,155 - $297,100	3,682 New	3,682 $265,000

64.7M

47.1K

Ticker ALLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,726,096
Market Cap $89.8M
Description
Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

Stay updated on Dupont Capital Management Corp with notifications on news.